ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

NSPH: Nanosphere Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

NANOSPHERE INC (NASD)
NSPH	6.05	-0.34	(-5.32%)	Vol. 27,561	12:12 ET

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene(r) System for direct genomic and ultra-sensitive protein detection. It is easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL.

General Information

NANOSPHERE INC

4088 Commercial Avenue Northbrook, IL 60062 Phone: 847 400-9000 Fax: 847 400-9199 Web: www.nanosphere.us Email: None

Industry	MED-BIOMED/GENE
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/25/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	6.39
52 Week High	8.61
52 Week Low	2.71
Beta	1.48
20 Day Moving Average	94,521.60
Target Price Consensus	7.88

% Price Change
4 Week	5.21
12 Week	-19.12
YTD	31.51

% Price Change Relative to S&P 500
4 Week	4.07
12 Week	-23.75
YTD	8.84

Share Information
Shares Outstanding (millions)	22.23
Market Capitalization (millions)	139.16
Short Ratio	3.04
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	-0.33
Current Year EPS Consensus Estimate	-1.44
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	02/25/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.67
30 Days Ago	1.67
60 Days Ago	1.67
90 Days Ago	1.67

Fundamental Ratios

P/E
Current FY Estimate:	-
Trailing 12 Months:	-
PEG Ratio	-

EPS Growth
vs. Previous Year	9.76%
vs. Previous Quarter	2.63%

Sales Growth
vs. Previous Year	157.60%
vs. Previous Quarter:	81.34%

Price Ratios
Price/Book	2.70
Price/Cash Flow	-
Price / Sales	81.91

ROE
09/30/09	-54.37
06/30/09	-49.40
03/31/09	-45.68

ROA
09/30/09	-46.33
06/30/09	-42.44
03/31/09	-39.37

Current Ratio
09/30/09	5.40
06/30/09	6.40
03/31/09	7.92

Quick Ratio
09/30/09	5.24
06/30/09	6.22
03/31/09	7.70

Operating Margin
09/30/09	-2,018.60
06/30/09	-2,799.68
03/31/09	-18.68

Net Margin
09/30/09	-2,018.83
06/30/09	-2,799.68
03/31/09	-18.68

Pre-Tax Margin
09/30/09	-2,018.83
06/30/09	-2,799.68
03/31/09	-18.68

Book Value
09/30/09	2.32
06/30/09	2.66
03/31/09	3.01

Inventory Turnover
09/30/09	1.14
06/30/09	0.90
03/31/09	0.71

Debt-to-Equity
09/30/09	0.00
06/30/09	0.02
03/31/09	0.03

Debt to Capital
09/30/09	0.00
06/30/09	1.63
03/31/09	3.17


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research